Predict your next investment

Neumora Therapeutics company logo
HEALTHCARE | Drug Development

See what CB Insights has to offer

Founded Year



Series A | Alive

Total Raised


Last Raised

$500M | 4 mos ago

About Neumora Therapeutics

Neumora Therapeutics develops precision medicines to restore brain health and wellbeing. It offers a data-driven precision neuro platform to cut through brain disease heterogeneity to match the right patient populations to targeted therapeutics. Its solution is to develop proprietary Data Biopsies by integrating multiple data types to provide a more complete picture of the specific mechanisms that drive brain diseases in specific patient populations.

Neumora Therapeutics Headquarter Location

65 Grove Street Suite 102

Watertown, Massachusetts, 02472,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Neumora Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Neumora Therapeutics is included in 1 Expert Collection, including Digital Health.


Digital Health

12,265 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Neumora Therapeutics Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Neumora Therapeutics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.